ストックスクリーナーアプリを入手
14.79
7.64%
1.05
前日終値:
$13.74
開ける：
$13.89
24時間の取引高:
110.45K
Relative Volume:
1.35
時価総額：
$393.13M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+16.09%
1か月 パフォーマンス:
+11.62%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$13.68
$14.97
1週間の範囲:
$12.84
$14.97
52週間の値動き範囲:
$11.81
$15.10
Carlsmed Inc Stock (CARL) Company Profile
CARL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
14.79 | 361.50M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-18 | 開始されました | BTIG Research | Buy |
| 2025-08-18 | 開始されました | BofA Securities | Buy |
| 2025-08-18 | 開始されました | Goldman | Buy |
| 2025-08-18 | 開始されました | Piper Sandler | Overweight |
| 2025-08-18 | 開始されました | Truist | Buy |
Carlsmed Inc (CARL) 最新ニュース
Carlsmed initiated with Buy at Truist on business potential - MSN
Carlsmed Q2 2025 revenue up 99% to USD 12.1M - Medical Buyer
Carlsmed stock rating reiterated at Buy by Goldman Sachs on growth outlook - Investing.com Australia
Carlsmed, Inc.: Strong Financial Performance and Growth Potential Justify Buy Rating - TipRanks
Carlsmed, Inc.: Strong Performance and Promising Growth Prospects with Upcoming Product Launch - TipRanks
UPDATECarlsmed® Reports Second Quarter 2025 Financial Results - The Manila Times
Carlsmed Reports Strong Growth in Q2 2025 Earnings - TipRanks
Carlsmed 2025 Q2 Earnings Strong Revenue Growth Despite Widening Net Loss - AInvest
Carlsmed: A High-Growth AI-Driven MedTech Play in Spine Surgery - AInvest
Earnings call transcript: Carlsmed’s Q2 2025 revenue surges, stock rises - Investing.com
Carlsmed Q2 Loss Narrows, Revenue Rises - MarketScreener
Carlsmed reports second quarter 2025 financial results - MarketScreener
Carlsmed® Q2 2025 Financial Performance: Assessing Long-Term Growth Potential in the AI-Driven Spine Surgery Revolution - AInvest
CARLSMED, INC. SEC 10-Q Report - TradingView
Carlsmed, Inc.'s Q2 2025 Performance and Strategic Momentum: A Disruptive Force in AI-Driven Spine Surgery - AInvest
Carlsmed® Reports Second Quarter 2025 Financial Results - MarketScreener
99% Growth: AI Spine Surgery Pioneer Carlsmed Hits $12.1M Revenue, Expands into Cervical Procedures - Stock Titan
Carlsmed CARL 2025Q2 Earnings Preview Upside Potential on AI-Driven Spine Solutions - AInvest
Two AI Small Caps Nobody Noticed - Nanalyze
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Truist Securities initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Australia
Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Truist Initiates Buy on Carlsmed with Focus on Business Growth Potential - AInvest
Carlsmed initiated with Buy at Truist on business potential (CARL) - Seeking Alpha
BofA Securities Initiates Coverage on Carlsmed With Buy Rating, $16 Price Target - MarketScreener
This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Goldman Sachs Initiates Coverage on Carlsmed With Buy Rating, $19 Price Target - MarketScreener
Carlsmed initiated with a Buy at BTIG - TipRanks
Truist Securities initiates coverage on Carlsmed stock with Buy rating - Investing.com
Truist Initiates Carlsmed at Buy With $18 Price Target - MarketScreener
Piper Sandler initiates coverage on Carlsmed with an Overweight rating, PT of $18. - AInvest
Buy Rating for Carlsmed: Innovative Aprevo Technology and Strong Growth Projections Justify Premium Valuation - TipRanks
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech - Investing.com
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech By Investing.com - Investing.com South Africa
Carlsmed initiated with an Overweight at Piper Sandler - TipRanks
Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential - Investing.com India
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Canada
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating - Investing.com
Carlsmed initiated with a Buy at Goldman Sachs - MSN
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - Stocktwits
AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN
Carlsmed, Inc. shares fall 2.01% after-hours as it prepares to report Q2 2025 financial results. - AInvest
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - The Manila Times
Carlsmed to report Q2 2025 financial results on Aug 28, 2025. - AInvest
Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week
Heartflow raises $317M, pops 66% at market open - BioWorld MedTech
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry
Carlsmed Inc (CARL) 財務データ
Carlsmed Inc (CARL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Carlsmed Inc (CARL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
| Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
| YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
3.30%
0.78%
大文字化:
|
ボリューム (24 時間):